Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @OutsourcPharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @OutsourcPharma
-
PPD
@PPDCRO prices IPO, seeking $1.5bn at a $9bn valuationhttps://www.outsourcing-pharma.com/Article/2020/02/03/PPD-seeks-1.5bn-through-IPO#.Xjk661KAtdc.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Year begins with bang for
#AI drug developmenthttps://www.outsourcing-pharma.com/Article/2020/01/31/AI-takes-leap-forward-in-drug-research#.Xjk63gkm13Q.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First entirely AI developed drug green lit for clinical trialhttps://www.outsourcing-pharma.com/Article/2020/01/30/AI-developed-drug-goes-to-trial#.Xjk6eoPgzpw.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
White males overrepresented in
#clinical trials for first-time#cancer treatmenthttps://www.outsourcing-pharma.com/Article/2020/01/24/White-males-overrepresented-in-clinical-trials#.Xi8QPrbJrpY.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CRO Novotech
@novotechCRO invests in Algernon, lands deal to run trialhttps://www.outsourcing-pharma.com/Article/2020/01/27/CRO-Novotech-invests-in-Algernon#.Xi8P07VJs6U.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Reporting of clinical trial results is ‘poor and not improving’https://www.outsourcing-pharma.com/Article/2020/01/21/Reporting-of-clinical-trial-results-remain-low#.XicpbEsUKsc.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Covance guns for more late-phase contract wins to drive growthhttps://www.outsourcing-pharma.com/Article/2020/01/21/Covance-guns-for-more-late-phase-contracts#.XicpZPv1xzc.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Takeda forms broad drug discovery pact with Charles Riverhttps://www.outsourcing-pharma.com/Article/2020/01/21/Takeda-forms-drug-discovery-pact-with-Charles-River#.XicpXwFSqc4.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Drug discovery service provider
@Schrodinger files for $100M IPOhttps://www.outsourcing-pharma.com/Article/2020/01/20/Schroedinger-files-for-100M-IPO#.XiXiHzLUdlM.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Outsourcing-Pharma proslijedio/la je Tweet
This recent
@OutsourcPharma article features an interview with ICON's Andrew Garrett, speaking about the integration of#artificialintelligence (AI) in R&D http://ow.ly/98FR50xpsn9 pic.twitter.com/ohw9FnMuJD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#FDA places Innate#cancer trial on partial clinical hold over CMO issuehttps://www.outsourcing-pharma.com/Article/2020/01/14/FDA-places-Innate-cancer-trial-on-hold#.Xh3bbiD3jlM.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bristol-Myers
@bmsnews offloads manufacturing plant to@CatalentPharmahttps://www.outsourcing-pharma.com/Article/2020/01/13/Bristol-Myers-offloads-manufacturing-plant-to-Catalent#.XhyFzpwq0XU.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Ex-Covance CEO Ratliff takes over as head of AMRIhttps://www.outsourcing-pharma.com/Article/2019/12/13/Ex-Covance-CEO-Ratliff-takes-over-as-head-of-AMRI#.XgCV501qu4E.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Combined in-vivo and in-vitro capabilities for faster efficacy assessmenthttps://www.outsourcing-pharma.com/Article/2019/12/23/Amylgen-partners-with-Neuron-Experts#.XgCV1k7URC8.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
3M set to sell drug delivery
#CDMO for $650mhttps://www.outsourcing-pharma.com/Article/2019/12/23/3M-set-to-sell-drug-delivery-CDMO-for-650m#.XgCVv2egbKI.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Outsourcing-Pharma proslijedio/la je Tweet
IQVIA
#datascience and advanced#analytics expert Yilian Yuan met with@OutsourcPharma to discuss the extra effort required by the industry to realize the impact of#AI &#ML. Read more here: http://bit.ly/2S091f1 pic.twitter.com/SPVkR22pa5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.